Synergistic anticancer effect of combination of AZD6244 and BYL719 targeting KRAS mutant in non-small cell lung cancer

被引：0
|
作者：
Jho, Eun Hye [1 ]
Kang, Sin I. [1 ]
Bae, Yeon-Hee [1 ]
Park, Young Mee [1 ]
Sun, Jong-Mu [2 ]
Ahn, Jin Seok [2 ]
Park, Keunchil [2 ]
Ahn, Myung-Ju [2 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4453
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4453
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non-Small Cell Lung Cancer
    Shimamura, Takeshi
    Chen, Zhao
    Soucheray, Margaret
    Carretero, Julian
    Kikuchi, Eiki
    Tchaicha, Jeremy H.
    Gao, Yandi
    Cheng, Katherine A.
    Cohoon, Travis J.
    Qi, Jun
    Akbay, Esra
    Kimmelman, Alec C.
    Kung, Andrew L.
    Bradner, James E.
    Wong, Kwok-Kin
    CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6183 - 6192
  • [42] Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
    Li, Yunchang
    Hu, Lanlin
    Peng, Xinhao
    Xu, Huasheng
    Tang, Bo
    Xu, Chuan
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 129 - 146
  • [43] KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
    Xie, Mingying
    Xu, Xiaoling
    Fan, Yun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Targeting KRAS mutant non-small cell lung cancer with EGFR aptamer displaying 3WJ pRNA nanoparticles
    Yang, Linlin
    Li, Zhefeng
    Guo, Peixuan
    Williams, Terence M.
    CANCER RESEARCH, 2022, 82 (12)
  • [45] FAK-targeting PROTAC demonstrates enhanced antitumor activity against KRAS mutant non-small cell lung cancer
    Liu, Jinyuan
    Xue, Lei
    Xu, Xiang
    Luo, Jinhua
    Zhang, Shijiang
    EXPERIMENTAL CELL RESEARCH, 2021, 408 (02)
  • [46] Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer
    Fu, Bingjie
    Dou, Xiaojing
    Zou, Miao
    Lu, Hao
    Wang, Kaixuan
    Liu, Qingxia
    Liu, Yao
    Wang, Wei
    Jin, Meihua
    Kong, Dexin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells
    Xie, Chun
    Li, Ying
    Li, Lan-Lan
    Fan, Xing-Xing
    Wang, Yu-Wei
    Wei, Chun-Li
    Liu, Liang
    Leung, Elaine Lai-Han
    Yao, Xiao-Jun
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [48] Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications
    Ricciuti, Biagio
    Leonardi, Giulia Costanza
    Metro, Giulio
    Grignani, Francesco
    Paglialunga, Luca
    Bellezza, Guido
    Baglivo, Sara
    Mencaroni, Clelia
    Baldi, Alice
    Zicari, Daniela
    Crino, Lucio
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 53 - 68
  • [49] Frequency of KRAS Subtypes in Non-Small Cell Lung Cancer
    Biernacka, Anna
    Tsongalis, Peter D.
    Peterson, Jason D.
    de Abreu, Francine
    Black, Candice C.
    Gutmann, Edward
    Liu, Xiaoying
    Padmanabhan, Vijayalakshmi
    Tafe, Laura J.
    Amos, Christopher I.
    Tsongalis, Gregory J.
    MODERN PATHOLOGY, 2016, 29 : 451A - 451A
  • [50] Current perspectives of KRAS in non-small cell lung cancer
    Harris, Ethan
    Thawani, Rajat
    CURRENT PROBLEMS IN CANCER, 2024, 51
12345